The findings reported here suggest that safranal’s anti-cancer properties could be attributed to its anti-inflammatory activities through downregulation of NF-κB, COX-2, and iNOS expression levels as well as to the reduction of both TNF-α and its receptor TNFR1. This evidence concerns the gene TNF and cancer.